Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Biliary Tract Neoplasms × Carboplatin × Clear all

Phase

Phase 1/2 2 Phase 3 1 Phase 2 1 Phase 1 1

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 162 Ovarian Neoplasms 56 Lung Neoplasms 55 Breast Neoplasms 30 Fallopian Tube Neoplasms 29 Small Cell Lung Carcinoma 28 Parkinson Disease 4, Autosomal Dominant Lewy Body 24 Carcinoma, Ovarian Epithelial 22 Uterine Cervical Neoplasms 18 Triple Negative Breast Neoplasms 18 Neuroblastoma 16 Carcinoma 15 Squamous Cell Carcinoma of Head and Neck 14 Neoplasm Metastasis 12 Endometrial Neoplasms 12 Adenocarcinoma of Lung 11 Neoplasms 10 Head and Neck Neoplasms 9 Recurrence 8 Peritoneal Neoplasms 7 Central Nervous System Neoplasms 7 Carcinoma, Transitional Cell 7 Brenner Tumor 7 Esophageal Neoplasms 6 Urinary Bladder Neoplasms 5 Testicular Neoplasms 5 Lung Diseases 5 Hepatoblastoma 5 Thoracic Neoplasms 4 Teratoma 4

Interventions

Gemcitabine 12 Cisplatin 10 durvalumab 7 S 1 (combination) 3 Oxaliplatin 3 Leucovorin 3 Capecitabine 3 zanidatamab 2 gemcitabine-oxaliplatin regimen 2 Trastuzumab 2 Fluorouracil 2 trastuzumab deruxtecan 1 pembrolizumab 1 niraparib 1 neratinib 1 ivosidenib 1 futibatinib 1 envafolimab 1 encorafenib 1 binimetinib 1 becatecarin 1 Tegafur 1 Pancreaticojejunostomy 1 Irinotecan 1 Folfox protocol 1 Drug Therapy 1 Chemotherapy, Adjuvant 1 Carboplatin 1 Albumin-Bound Paclitaxel 1 130-nm albumin-bound paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05771480 2026-02-23

TOURMALINE

AstraZeneca

Phase 3 Active not recruiting

Gastrointestinal

Biliary Tract Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡